BSEBoard Meeting4d ago · 9 Aug 2026, 06:37 pm
Dolphin Medical Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Board Meeting Intimation ....
Dolphin Medical Services Ltd · 526504
✦ AI SummaryResults
Dolphin Medical Services Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026, inter alia, to consider and approve the unaudited standalone financial results of the Company for the 1st quarter ended June 30, 2026 of the Financial Year 2026-27.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Dolphin Medical Services Ltd - 526504 - Board Meeting Intimation for BM Intimation For BM Is Scheduled To Be Held On Thursday, August 14, 2026, Inter Alia, To Consider & Approve The Unaudited Standalone Financial Results Of The Company For The 1St Quarter Ended June 30, 2026 Of The Financial Year 2026-27
Attachments (1)
📄pdf
Download →
02589072-5ca3-4935-b1be-ccd7bb695c18.pdf
View document text
To Date: 8/9/2026
The Manager
Department of Corporate Services
Bombay Stock Exchange Limited
Phiroze Jeejeebhoy Towers Dalal
Street
MUMBAI - 400 001.
Scrip Code: 526504, DOLPHIN MEDICAL SERVICES LIMITED
Ref: Regulation 29(1) of Securities and·Exchange Board of India (Listing Obligations and
Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations").
Dear Sir/Madam,
Pursuant to Regulation 29(1) of the SEBI Listing Regulations, this is to inform that a meeting of the
Board of Directors of the Company is scheduled to be held on Friday, August 14, 2026, inter alia, to
consider & approve the Unaudited Standalone Financial Results of the Company for the 1st Quarter
ended June 30, 2026 of the Financial Year 2026-27.
Further, in continuation to our earlier intimation dated June 26,2026, in compliance with the provisions
of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, and the
Company's "Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of
Trading in Securities by Insiders", the Trading Window for dealing in the securities of the Company for
all the Designated Persons, including Insiders, had already been closed with effect from July 01, 2026,
and will remain closed till 48 hours after the publication of the financial results.
Thanking you,
Yours faithfully
for DOLPHIN MEDICAL SERVICES LIMITED
Mallour Rajesh Kumar
Director
DIN:08125774